Etiometry is the First to Achieve FDA Clearance of an AI-Based Risk Algorithm that Alerts for Inadequate Oxygenation of Adult Patients in Critical Care

U.S. Hospitals can now equip clinicians in adult ICUs with Etiometry’s IDO2 Index™ to rapidly identify changes to patients’ condition. BOSTON, Mass. – January 24, 2023 – Etiometry, a leader in clinical decision-support software, announced today its IDO2 Index™ was cleared for adult use by the Food and Drug Administration. Now, U.S. hospitals can arm…

Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution

The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, TX. – November 29th, 2022 – Frost & Sullivan recently assessed the US clinical decision support for the critical care industry and, based on its findings, recognizes Etiometry with…

Etiometry’s Clinical Decision-Support Software Receives CE Mark

This marks the latest regulatory approval for Etiometry as the second adult and third pediatric market authorization October 12, 2022 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, announced today that the company has obtained the CE Mark under the European Union’s medical device regulation, marking the…

Etiometry Expands AI Software Platform Portfolio with 2 New FDA-Cleared Algorithms for Managing Critical Care Patients

BOSTON, Mass. – July 12, 2022 – Etiometry, a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care. Etiometry is the only critical care AI decision-support…

Radiometer and Etiometry Announce Partnership to Enhance Neonatal Intensive Care Clinical Workflows and Patient Outcomes

Leading Intensive Care Clinical Decision-Support Software and Acute Care Diagnostics Medical Device Provider Announce Partnership BOSTON, Mass. & BREA, Cali. – June 30, 2022 – Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance…

Etiometry Surpasses 100 Contracted Units in Year of Record Growth

Leading Intensive Care Clinical Decision-Support Solution Secures New Funding and Inks Strategic Collaborations and Clients to Fuel Expansion BOSTON – January 20, 2022 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today, announced substantial business growth and expansion in 2021. The successful year for Etiometry included achieving new sales milestones,…

Etiometry and Terumo Cardiovascular Announce Partnership to Deliver Enhanced Monitoring Insights for Adult Cardiac Surgery Patients

New partnership will enable clinical decision-support solutions to improve perioperative care BOSTON  & ANN ARBOR, MI – September 9, 2021 — Etiometry, a leader in clinical decision-support software for critical care, today jointly announced a new collaboration with Terumo Cardiovascular, a global leader in cardiovascular surgery technologies and a subsidiary of Japan-based Terumo Corporation (TSE: 4543). The…

Etiometry Raises $9M in Series A-3 Funding to Fuel Business and Leadership Team Expansion, R&D Acceleration, and Clinical Initiatives

Following impressive growth in 2020, the new capital will enable Etiometry to extend use of its ICU clinical decision-support software to other hospital care settings. BOSTON – June 3, 2021 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today announced a fully subscribed $9 million Series A-3 extension raise to…